Tag: biotechnology company

May 17, 2019

Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell Therapeutics Corp.

Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 1,698,000 common shares (the “Shares”) of BriaCell Therapeutics...
May 15, 2019

Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations

Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)  (the "Company" or "Lexaria"), a drug delivery platform innovator, has proven in animal testing that...
May 13, 2019

BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders

BriaCell Therapeutics Corp. (TSX:BCT, OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announced that...
May 10, 2019

BriaCell Therapeutics: Process Development Critical to Drug Design Process

BriaCell Therapeutics (TSXV:BCT) (OTCQB:BCTXF) CEO Bill Williams was recently featured in BioPharm International.
May 8, 2019

Pascal Biosciences Announces Formation of Clinical Advisory Board

Pascal Biosciences Inc. (TSXV:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced it has formed a clinical...
May 7, 2019

Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company

Lexaria Bioscience Corp. (CSE:LXX, OCTQX:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that it has entered a...
April 25, 2019

Lexaria Bioscience Expands Advisory Board

Lexaria Bioscience Corp. (CSE:LXX, OCTQX:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, is pleased to announce new appointments...